Soft tissue bursitis of the right elbow that is not classified as olecranon bursitis — used for overuse- or pressure-related bursal inflammation at other anatomical sites around the right elbow joint.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Elbow
Documentation tips
What should appear in the chart to support M70.31.
Source · Editorial brief grounded in 5 cited references ↓
- Specify 'right elbow' explicitly in the assessment — avoid ambiguous terms like 'dominant elbow' without also naming the side.
- Identify the specific bursal site (e.g., radiohumeral, bicipitoradial) to distinguish M70.31 from olecranon bursitis (M70.21); if documentation only states 'elbow bursitis,' query the provider for site specificity.
- Record imaging findings — ultrasound or MRI evidence of bursal fluid, thickening, or periarticular inflammation — to support medical necessity for injection procedures billed alongside this diagnosis.
- Document the occupational or activity-related etiology when present and add a Y93 external cause code to reflect the overuse mechanism, as required by the M70 category guidelines.
- Note prior conservative management (NSAIDs, activity modification, physical therapy) in the note when proceeding to injection — this supports medical necessity under applicable LCDs.
Related CPT procedures
Procedure codes commonly billed with M70.31. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M70.31 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M70.31 when the bursa involved is actually the olecranon bursa — that maps to M70.21 (olecranon bursitis, right elbow), a distinct code with its own reimbursement pathway.
- Defaulting to M70.30 (unspecified elbow) when the provider has clearly documented the right side — always use the lateralized code when documentation supports it.
- Confusing M70.31 with M71.121 (other infective bursitis, right elbow) — M70.31 is for non-infective, use/overuse/pressure-related bursitis; if infection is documented, M71.121 applies instead.
- Failing to add an external cause code (Y93 series) when the bursitis is clearly occupation- or activity-related, as the M70 category includes a 'Use Additional' instruction for activity codes.
- Billing M70.31 as the sole diagnosis on a claim for CPT 20610/20611 without supporting documentation of bursal site, laterality, and failed conservative care — this is a common LCD audit trigger.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M70.31 covers non-olecranon bursitis of the right elbow that arises from repetitive use, overuse, or sustained pressure — the defining characteristic of the M70 category. Common presentations include radiocubital (radiohumeral) bursitis or other periarticular bursal inflammation not localized to the olecranon bursa. If the bursa involved is specifically the olecranon bursa, use M70.21 (olecranon bursitis, right elbow) instead. Reserve M70.31 for documented bursitis at an alternate elbow bursal site, or when imaging confirms non-olecranon periarticular bursal pathology.
The M70.3x subcategory distinguishes laterality: M70.30 for unspecified elbow, M70.31 for right, and M70.32 for left. Do not use M70.30 if the operative or clinical note specifies the right side — payers may downcode or flag an unspecified code when a lateralized code is available and clinically documented. An external cause code from Y93 may be added to identify the activity driving the overuse.
M70.31 appears on CMS coverage lists supporting medical necessity for bursa injections (CPT 20610, 20611) and trigger point injections. Ensure the clinical note documents the specific bursal site, laterality, any imaging findings (ultrasound or MRI confirming bursal fluid or thickening), and conservative care already attempted — all of which underpin medical necessity for procedural reimbursement.
Sibling codes
Other billable codes under M70.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M70.21 and M70.31 for right elbow bursitis?
02Can M70.31 support medical necessity for a bursa injection (CPT 20610)?
03Should I use M70.30 if the chart says 'right elbow bursitis' but doesn't name the specific bursa?
04Is an external cause code required with M70.31?
05What if bursitis is present in both elbows?
06Can M70.31 be used for infective elbow bursitis?
07Does M70.31 require a 7th-character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 — code M70.31
- 02cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=60304&ver=3
- 03cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=57114&ver=13
- 04icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M70-M79/M70-/M70.31
- 05cms.govhttps://www.cms.gov/medicare/coding-billing/icd-10-codes
Mira AI Scribe
Mira captures the affected side (right elbow), the specific bursal site if named, imaging findings confirming bursal pathology, and any occupational or repetitive-use etiology from the encounter note. This prevents downcoding to unspecified M70.30, misassignment to olecranon bursitis (M70.21), or missing the Y93 external cause code — all common audit flags when billing elbow bursa injections.
See how Mira captures M70.31 documentation